Otofonix Encore vs Starkey Evolv AI

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.

The Starkey Evolv AI is a premium behind-the-ear prescription hearing aid released in 2022, currently available at $4,598. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #28 of 36 prescription hearing aids tested. This device shows notable strengths in specific performance areas. Music streaming quality stands out at 3.7/5, scoring 1.06 points above the category average—making it a solid choice for users who prioritize audio entertainment. Speech in noise performance reaches 2.8/5, which is 0.81 points above the category average, though the absolute score reflects mixed real-world performance in challenging listening environments. Speech in quiet is solid at 3.4/5, slightly above average. The Evolv AI does show weaknesses in two key areas. Own voice comfort scores 2.1/5, falling 0.65 points below the category average, which may affect how natural your own speech sounds. Feedback handling, while solid in absolute terms at 3.5/5, runs 1.21 points below the category average of 4.71/5—meaning competitors in this price tier generally offer better feedback suppression. At this premium price point, several alternatives deliver stronger overall performance, including the Phonak Sphere Infinio and Oticon Intent. However, the Evolv AI's Expert's Choice Award recognition in 2023 and 2024 reflects its practical strengths. This hearing aid may suit users who prioritize music streaming quality and improved speech understanding in noise over own-voice comfort, and who value Starkey's feature set including rechargeable batteries and hands-free calling for both iPhone and Android.